Skip to main content

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Publication ,  Journal Article
Tong, SYC; Davis, JS; Eichenberger, E; Holland, TL; Fowler, VG
Published in: Clin Microbiol Rev
July 2015

Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to β-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Microbiol Rev

DOI

EISSN

1098-6618

Publication Date

July 2015

Volume

28

Issue

3

Start / End Page

603 / 661

Location

United States

Related Subject Headings

  • beta-Lactam Resistance
  • Virulence Factors
  • Staphylococcus aureus
  • Staphylococcal Infections
  • Risk Factors
  • Prosthesis-Related Infections
  • Microbiology
  • Humans
  • Cross Infection
  • Community-Acquired Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015). Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev, 28(3), 603–661. https://doi.org/10.1128/CMR.00134-14
Tong, Steven Y. C., Joshua S. Davis, Emily Eichenberger, Thomas L. Holland, and Vance G. Fowler. “Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Clin Microbiol Rev 28, no. 3 (July 2015): 603–61. https://doi.org/10.1128/CMR.00134-14.
Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015 Jul;28(3):603–61.
Tong, Steven Y. C., et al. “Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Clin Microbiol Rev, vol. 28, no. 3, July 2015, pp. 603–61. Pubmed, doi:10.1128/CMR.00134-14.
Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015 Jul;28(3):603–661.

Published In

Clin Microbiol Rev

DOI

EISSN

1098-6618

Publication Date

July 2015

Volume

28

Issue

3

Start / End Page

603 / 661

Location

United States

Related Subject Headings

  • beta-Lactam Resistance
  • Virulence Factors
  • Staphylococcus aureus
  • Staphylococcal Infections
  • Risk Factors
  • Prosthesis-Related Infections
  • Microbiology
  • Humans
  • Cross Infection
  • Community-Acquired Infections